fda ends tirzepatide shortage says years-long is resolved, will give limited leeway to compounders GLP-1 Drugs: FDA “Re-Confirms” Decision

doi: 10.1016/j.neuroscience.2009.05.025 194 ZhangHSongBZhuWLiuLHeXWangZet al

While there have been case reports, large studies haven't shown a consistent increased risk compared to other diabetes medications

Then theres digestion speedor lack of it

This almost 100-fold difference in intrinsic clearance for both drugs, depending on the allelic variant considered, is of significance in the interpretation of clinical data

Your provider will guide you on a treatment regimen that may include an increase in dose every four weeks.You should not change your dosing regimen or stop taking compounded semaglutide as prescribed without discussing with your provider first